RELAY PRO Stent-Graft (Bolton Medical) – Incorrect Size (2024)
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
RELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 28-M4-30-095-30U; (c) Part number 28-M4-46-155-46U; (d) Part number 28-M4-32-155-32S; (e) Part number 28-M4-36-250-32S; (f) Part number 28-M4-38-145-34S; (g) Part number 28-M4-38-190-38S; (h) Part number 28-M4-44-105-44S; (i) Part number 28-N4-22-099-22S; (j) Part number 28-N4-22-159-22S; (k) Part number 28-N4-24-099-24
Brand
Bolton Medical Inc.
Lot Codes / Batch Numbers
(a) Part number 28-M4-34-100-34U - Lot #2112080111 and #2112080158, UDI 843576149656, (b) Part number 28-M4-30-095-30U - Lot #2112080147 and #2112080148, UDI 843576149632, (c) Part number 28-M4-46-155-46U - Lot #2112100328, UDI 843576149847, (d) Part number 28-M4-32-155-32S - Lot #B211209120, UDI 843576100183, (e) Part number 28-M4-36-250-32S - Lot #B211203197, UDI 843576100763, (f) Part number 28-M4-38-145-34S - Lot #B211206395, UDI 843576100572, (g) Part number 28-M4-38-190-38S - Lot #B211202319, UDI 843576100343, (h) Part number 28-M4-44-105-44S - Lot #B211209068, UDI 843576100114, (i) Part number 28-N4-22-099-22S - Lot #B211208120, UDI 843576100824, (j) Part number 28-N4-22-159-22S - Lot #B211208162, UDI 843576100954, (k) Part number 28-N4-24-099-24S - Lot #B211130071 and #B211207227, UDI 843576100831, (l) Part number 28-N4-28-204-24S - Lot #B211209065, UDI 843576101449, (m) Part number 28-N4-30-164-30U - Lot #2112100333, UDI 843576150584, (n) Part number 28-N4-32-164-28S - Lot #B211207181, UDI 843576101364, (o) Part number 28-N4-34-154-34U - Lot #2112090117, UDI 843576150607, (p) Part number 28-N4-34-209-30S - Lot #B211209073, UDI 843576101470, (q) Part number 28-CMP-3062-NC - Lot #2112100385, no UDI, and (r) Part number 28-CMP-3074-MC - Lot #2112100383, no UDI
Products Sold
(a) Part number 28-M4-34-100-34U - Lot #2112080111 and #2112080158, UDI 843576149656; (b) Part number 28-M4-30-095-30U - Lot #2112080147 and #2112080148, UDI 843576149632; (c) Part number 28-M4-46-155-46U - Lot #2112100328, UDI 843576149847; (d) Part number 28-M4-32-155-32S - Lot #B211209120, UDI 843576100183; (e) Part number 28-M4-36-250-32S - Lot #B211203197, UDI 843576100763; (f) Part number 28-M4-38-145-34S - Lot #B211206395, UDI 843576100572; (g) Part number 28-M4-38-190-38S - Lot #B211202319, UDI 843576100343; (h) Part number 28-M4-44-105-44S - Lot #B211209068, UDI 843576100114; (i) Part number 28-N4-22-099-22S - Lot #B211208120, UDI 843576100824; (j) Part number 28-N4-22-159-22S - Lot #B211208162, UDI 843576100954; (k) Part number 28-N4-24-099-24S - Lot #B211130071 and #B211207227, UDI 843576100831; (l) Part number 28-N4-28-204-24S - Lot #B211209065, UDI 843576101449; (m) Part number 28-N4-30-164-30U - Lot #2112100333, UDI 843576150584; (n) Part number 28-N4-32-164-28S - Lot #B211207181, UDI 843576101364; (o) Part number 28-N4-34-154-34U - Lot #2112090117, UDI 843576150607; (p) Part number 28-N4-34-209-30S - Lot #B211209073, UDI 843576101470; (q) Part number 28-CMP-3062-NC - Lot #2112100385, no UDI; and (r) Part number 28-CMP-3074-MC - Lot #2112100383, no UDI;
Bolton Medical Inc. is recalling RELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and pati due to The stent-graft inside the delivery system was the incorrect size.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The stent-graft inside the delivery system was the incorrect size.
Recommended Action
Per FDA guidance
The firm issued letters dated and issued on 2/22/2024 via certified mail to it's U.S. customers. For OUS customers, the letters will be issued by 3/8/2024 due to the need to translate the letters into their local languages. The letter explained the reason for recall, risk to health, and actions to be taken by the customer/user. The instructions included completing the Acknowledgement Form, retaining a copy of it, and informing Terumo Aortic of any adverse events concerning the use of the affected product. The Acknowledgement Form indicates the consignee has read and understands the information contained in the letter, has taken the appropriate action, and disseminated the information to any affected staff, service, and/or facilities.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026